Navigation Links
New Drug Application Submitted for Investigational Antibiotic Doripenem

RARITAN, N.J., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for doripenem, an investigational carbapenem antibiotic for the treatment of nosocomial pneumonia, a pneumonia that is acquired in a hospital or other healthcare setting.

According to the Centers for Disease Control and Prevention (CDC), two million Americans develop hospital-acquired infections each year, and approximately 90,000 die as a result. Approximately 70 percent of these infections are resistant to at least one antibiotic. Pneumonia is the second, most-common, hospital-acquired infection in the United States and is associated with substantial morbidity and mortality.

Doripenem belongs to a class of antibacterial agents called carbapenems, which are useful in treating life-threatening infections caused by Gram-negative(1) and Gram-positive(2) bacteria. The data supporting the NDA showed doripenem was an effective treatment for hospital-acquired pneumonia. The data also demonstrated the effectiveness of doripenem against infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa and Enterobacteriaceae, including strains of these bacteria that are resistant to other therapies.

Pseudomonas aeruginosa is one of the leading causes of hospital-acquired infections and, because of increasing multi-drug resistance, treatment options are limited. In general, there are few antibiotics available or currently in development to treat the resistant infections - which can be potentially life-threatening - associated with these Gram-negative bacteria.

In clinical trials, doripenem was well-tolerated. The most common treatment-emergent adverse events seen were diarrhea, nausea, constipation, urinary tract infection and decubitus ulcer, commonly known as a bedsore.


'"/>




Page: 1

Related medicine news :

1. Prostate Cancer Can Be Treated By Application Of LASER Technology
2. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
3. Venus Remedies Files 5th International Patent Application
4. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
5. Recd Number of Abstracts Submitted for Sci Cong on Osteoporosis
6. Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke
7. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
8. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
9. Antibiotics Helps Autism
10. Antibiotics losing their power against acne
11. Antibiotic induces liver damage in children with E.COLI infections.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... Mt. Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... her patients on early orthodontic treatment and accepting new pediatric patients, with or without ... can help young patients have a better orthodontic outcome and experience. When patients receive ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of ... W’81, have made a $10 million gift to establish the Ken Moelis and ... a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... According to a new market research report "Medical Radiation Detection, Monitoring & ... Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End ... to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in ... Continue Reading ... ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... 2017  The Pharmaceutical Care Management Association (PCMA) today ... on patient out-of-pocket spending: ... (CMS), the average amount spent out-of-pocket for drugs continues ... in 2016, down from 23% in 2006. ... a coverage problem. Health plans don,t have unlimited funds ...
Breaking Medicine Technology: